Casa Verde led a £4.5m funding round in Mamedica.

Casa Verde, a private equity firm, led a £4.5m funding round in Mamedica, a United Kingdom based private clinic with a linked pharmacy which specializes in cannabis-based prescriptions. "We're excited to partner with Mamedica as the U.K. cannabis market enters a period of rapid growth. Mamedica's digital-first, patient-centric model sets the standard for care in the U.K. and offers a blueprint for broader European expansion," Karan Wadhera, Casa Verde Managing Partner.